If you're struggling to find what you need, call our Support line on 7 days a week, 8am-8pm. It is best to read this information with our general information about chemotherapy and breast cancer. FEC is usually given into a vein. You usually have it as an outpatient or during a hospital stay. Your cancer doctor or nurse will tell you how often you will have it. FEC can cause side effects.
Study record managers: refer to the Data Element Definitions if submitting registration or results information. Secondary Outcome Measures : The relation between pCR rate, molecular subtypes, and different regiments. Cohen's kappa statistic was used to determine inter-examiner agreement. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Treatment of early-stage breast cancer with adjuvant chemotherapy has improved survival. Results of retrospective analysis evaluating the effect of chemotherapy dose reduction have been mixed due to a heterogeneity in regimen selection, lack of adjustment for confounding variables, and inadequate follow-up to determine effect. Patient inclusion was based on receipt of a minimum of 4 and maximum of 6 cycles of adjuvant FEC-D, with at least 1 cycle of D administered. TCD cohorts are outlined in Figure 2A.
You have the drugs through a thin short tube a cannula that goes into a vein in your arm each time you have treatment. These are long plastic tubes that give the drug into a large vein in your chest or arm. The tube stays in place throughout the course of treatment. You have FEC-T every 3 weeks. You usually have up to 6 of cycles of treatment.